TRIMTECH Therapeutics Limited

🗓 Founded 2023👥 22 employees💰 Last funded Mar 2025
Biotechnology Research🌐 trimtechtherapeutics.com
Website LinkedIn
TRIMTECH has a growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTAC® and TRIMGLUE®. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Netherlands
1
United Kingdom
1
Frequently asked questions
Who invested in TRIMTECH Therapeutics Limited?
TRIMTECH Therapeutics Limited has 2 investors on record on gritt.io, including 2 early-stage backers.
When did TRIMTECH Therapeutics Limited last raise funding?
The most recent investment in TRIMTECH Therapeutics Limited recorded on gritt.io was in March 2025.
When was TRIMTECH Therapeutics Limited founded?
TRIMTECH Therapeutics Limited was founded in 2023.
What industry is TRIMTECH Therapeutics Limited in?
TRIMTECH Therapeutics Limited operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.